Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2012
10/30/2012CA2609349C Anti-mcp-1 antibodies, compositions, methods and uses
10/30/2012CA2595038C Modified tie-2 receptor ligands
10/30/2012CA2525184C Il-23p40 specific immunoglobulin derived proteins, compositions, methods and uses
10/30/2012CA2512639C Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
10/30/2012CA2411374C Dual specificity antibodies and methods of making and using
10/30/2012CA2399790C Cd40 ligand adjuvant for respiratory syncytial virus
10/30/2012CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/30/2012CA2215161C Proteinase k resistant surface protein of neisseria meningitidis
10/26/2012WO2012145759A2 Methods of protein production and compositions thereof
10/26/2012WO2012145746A1 Compositions and methods for the treatment of neuromyelitis optica
10/26/2012WO2012145739A1 Compositions and methods for stabilization of active agents
10/26/2012WO2012145714A2 Prostate-specific membrane antigen binding proteins and related compositions and methods
10/26/2012WO2012145673A1 Antibody polypeptides that antagonize cd40
10/26/2012WO2012145671A1 Radioisotope-photodynamic therapy for cancer treatment
10/26/2012WO2012145666A1 Peptide and conjugate vaccines for fungal infections
10/26/2012WO2012145577A1 Adjuvanted rabies vaccine with improved viscosity profile
10/26/2012WO2012145572A1 Regimens and compositions for aav-mediated passive immunization of airborne pathogens
10/26/2012WO2012145568A1 Antibodies to human b7x for treatment of metastatic cancer
10/26/2012WO2012145509A2 Adeno-associated-virus rep sequences, vectors, and viruses
10/26/2012WO2012145507A2 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/26/2012WO2012145493A1 Antibodies and other molecules that bind b7-h1 and pd-1
10/26/2012WO2012145417A1 Method for treating osteoporosis
10/26/2012WO2012145355A1 Vaccine delivery method
10/26/2012WO2012145238A2 Methods for reducing an adverse immune response to a foreign antigen in a human subject with anti-cd4 antibodies or cd4-binding fragments thereof or cd4-binding molecules
10/26/2012WO2012145183A2 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
10/26/2012WO2012145125A1 Targeted radionuclides
10/26/2012WO2012144726A2 Tumor antigen proteins or genes of polo-like kinase 1
10/26/2012WO2012144692A1 Humanized anti-emap ii antibody and use thereof
10/26/2012WO2012144676A1 Chemokine expression regulator
10/26/2012WO2012144579A1 Antibody preparation having solution form
10/26/2012WO2012144376A1 Therapeutic or prophylactic agent for osteoarthritis
10/26/2012WO2012144208A1 Diagnosis and treatment of cancer using anti-itm2a antibody
10/26/2012WO2012143902A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/26/2012WO2012143732A1 Process for preparing vaccine composition
10/26/2012WO2012143524A2 Bispecific antibodies against her2 and cd3
10/26/2012WO2012143523A1 Bispecifc antibodies against her2
10/26/2012WO2012143498A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012WO2012143375A2 Novel hypoallergens
10/26/2012WO2012143374A1 Hypoallergen
10/26/2012WO2012142696A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012WO2012142684A1 Method for constructing an attenuated mutant strain of pathogenic bacteria, vaccine, vaccine vector and use of said vaccine
10/26/2012WO2012142662A1 Modified variable domain molecules and methods for producing and using them b
10/26/2012WO2012116142A3 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
10/26/2012WO2012108650A3 Uses of a monoclonal antibody to proteinase-3 as a therapeutic agent or as a diagnostic agent for a stroke
10/26/2012WO2012097049A3 Dna repair enzyme inhibitor nanoparticles and uses thereof
10/26/2012WO2012089742A3 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
10/26/2012WO2012075490A3 Anti-podoplanin antibodies and methods of use
10/26/2012WO2012074966A3 Improved production of anti-peptide antibodies
10/26/2012WO2012049431A3 Use of an anti-cd20 antibody for treating primary cerebral lymphoma
10/26/2012WO2012024659A3 Antibody-based constructs directed against tyrosine kinase receptors
10/26/2012WO2011138040A3 Vaccine against beta-herpesvirus infection and use thereof
10/26/2012CA2833879A1 Compositions and methods for stabilization of active agents
10/26/2012CA2833785A1 Compositions and methods for the treatment of neuromyelitis optica
10/26/2012CA2833743A1 Antibody polypeptides that antagonize cd40
10/26/2012CA2833668A1 Novel hypoallergens
10/26/2012CA2833643A1 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/26/2012CA2833636A1 Antibodies and other molecules that bind b7-h1 and pd-1
10/26/2012CA2833614A1 Locally-active anticoagulants and anti-inflammatory agents
10/26/2012CA2833404A1 Modified variable domain molecules and methods for producing and using them b
10/26/2012CA2833369A1 Vaccine delivery method
10/26/2012CA2833319A1 Process for preparing vaccine composition
10/26/2012CA2833289A1 Method for treating osteoporosis
10/26/2012CA2833081A1 Hypoallergen
10/26/2012CA2833019A1 Prostate-specific membrane antigen binding proteins and related compositions and methods
10/26/2012CA2832712A1 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/26/2012CA2832510A1 Bcma-based stratification and therapy for multiple myeloma patients
10/26/2012CA2832389A1 Bispecific antibodies against her2 and cd3
10/26/2012CA2832387A1 Bispecifc antibodies against her2
10/26/2012CA2830972A1 Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
10/25/2012US20120270265 Methods of obtaining a specific binding member that binds eotaxin
10/25/2012US20120270232 Characterization of granulocytic ehrlichia and methods of use
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120270202 Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
10/25/2012US20120269885 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269884 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269883 MicroRNA-140-5P as a Tumor Suppressor and Sensitizing Agent for Chemotherapy
10/25/2012US20120269861 Treatment of breast cancer with iodonitrobenzamides in combination with anti-tumor agents
10/25/2012US20120269859 Multimer of extracellular domain of cell surface functional molecule
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269857 Analogs of alpha galactosylceramide and uses thereof
10/25/2012US20120269856 Stable immunogenic protein having multiple cysteines molecules process therefor and composition thereof
10/25/2012US20120269855 Toll-like receptor 5 ligands and methods of use
10/25/2012US20120269854 Method of Enhancing KSHV LANA1 Immunogenicity
10/25/2012US20120269853 Attenuated dengue virus vaccine containing adaptive mutation from mrc-5 cells
10/25/2012US20120269852 Adjuvated Influenza Vaccine and Use Thereof
10/25/2012US20120269851 Expression cassettes endcoding hiv-1 south african subtype c modified proteins
10/25/2012US20120269850 Method of Inducing an Immune Response
10/25/2012US20120269849 Attenuated influenza viruses and vaccines
10/25/2012US20120269848 Compositions and methods for treating and preventing infection
10/25/2012US20120269847 Antigen purification process for pertactin antigen
10/25/2012US20120269846 Adjuvanted Rabies Vaccine with Improved Viscosity Profile
10/25/2012US20120269844 Vaccines for the treatment of neoplasias from viral capsids of birnavirus containing antigens of the human papillomavirus
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269842 Enterotoxigenic e. coli fusion protein vaccines
10/25/2012US20120269841 Compositions relating to a mutant clostridium difficile toxin and methods thereof
10/25/2012US20120269840 Expression of hiv polypeptides and production of virus-like particles
10/25/2012US20120269839 Hmgn polypeptides as immune enhancers and hmgn antagonists as immune suppressants
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/25/2012US20120269836 Vaccine
1 ... 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 ... 1823